ADMA Biologics Inc vs Xcel Energy Inc — how do they compare? ADMA Biologics Inc trades at $9.86 (market cap $2.22B), while Xcel Energy Inc trades at $77.94 (market cap $48.51B). The key difference: Xcel Energy Inc is far larger — about 21.9× ADMA Biologics Inc's market cap, and Xcel Energy Inc pays a 3.05% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | XEL | |
|---|---|---|
Market Cap | $2.22B | $48.51B |
Sector | Health | Utilities |
52-Week High | $20.38 | $83.91 |
52-Week Low | $7.60 | $71.75 |
Enterprise Value | $2.29B | $86.82B |
Dividend Yield | — | 3.05% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Xcel Energy (XEL) trades at $76.87, down 1.54% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $0.93 per share, beating estimates, and maintains a solid dividend. Revenue for 2025 was $14.67 billion with a net income margin of 15.28%, while analyst consensus is bullish with a $93.80 price target.
The outlook is supported by earnings growth and a $60 billion capital investment plan, but risks include regulatory pushback and high debt levels. The stock offers a stable investment opportunity with growth potential from infrastructure spending, though affordability concerns and interest rate sensitivity pose challenges.
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →